How Big Pharma is fighting Biden's program to lower drug costs for seniors
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Stay updated with breaking news from Foundation Litigation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
TRENTON, N.J. - Pharmaceutical giants are mounting a vigorous legal battle against President Biden’s plan to lower seniors’ prescription drug costs, urging federal judges here and around the country to invalidate a new program that aims to reduce the price of medications for high blood pressure, heart disease, cancer and diabetes. In a flurry of lawsuits, these drugmakers have blasted the government initiative as unconstitutional, defended their pricing practices and warned that regulation could
Nursing homes could find themselves open to civil rights and consumer protection lawsuits if the AARP's legal arm is successful.
Medicare drug price negotiations are due to start Sept. 1 with the first 10 prescriptions. But some drug companies are asking courts to postpone.